Details for New Drug Application (NDA): 216582
✉ Email this page to a colleague
The generic ingredient in PEMETREXED DISODIUM is pemetrexed disodium. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pemetrexed disodium profile page.
Summary for 216582
Tradename: | PEMETREXED DISODIUM |
Applicant: | Prinston Inc |
Ingredient: | pemetrexed disodium |
Patents: | 0 |
Pharmacology for NDA: 216582
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Medical Subject Heading (MeSH) Categories for 216582
Suppliers and Packaging for NDA: 216582
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 216582 | ANDA | Solco Healthcare US, LLC | 43547-632 | 43547-632-01 | 100 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (43547-632-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 100MG BASE/VIAL | ||||
Approval Date: | Dec 11, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription